BVNRY Financials: Bavarian Nordic A/S AI Analysis

Home

Stock

BVNRY

Financials

BVNRY Financial

Bavarian Nordic A/S

$9.64

-0.1%

$0

At close: Mar 24, 16:00:00 GMT-4

$9.64

Post-market: Mar 24, 18:09:59 GMT-4

Overview Forecast Earnings Dividends Financials

Income

Balance sheet

Cash flow

Annual

Quarterly

BVNRY Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	6,243	6,243	5,716	7,062	3,150	1,897
Revenue Growth (YoY)	9%	9%	-19%	124%	66%	2%
Cost of Revenue	3,195	3,195	2,897	2,459	1,449	1,326
Gross Profit	3,048	3,048	2,818	4,603	1,701	570
Selling, General & Admin	1,274	1,229	957	751	548	450
Research & Development	780	773	842	1,650	1,176	394
Operating Expenses	1,244	1,244	1,878	2,478	1,772	883
Other Non Operating Income (Expenses)	-28	-28	-81	-99	-48	-101
Pretax Income	1,800	1,800	971	1,482	-331	-454
Income Tax Expense	425	425	-16	7	15	10
Net Income	1,375	1,375	987	1,475	-347	-464
Net Income Growth	39%	39%	-33%	-525%	-25%	-268%
Shares Outstanding (Diluted)	71.79	78.02	78.1	76.71	70.41	63.1
Shares Change (YoY)	-10%	0%	2%	9%	12%	17%
EPS (Diluted)	19.15	17.62	12.64	19.23	-4.93	-7.36
EPS Growth	55%	39%	-34%	-490%	-33%	-243%
Free Cash Flow	1,362	1,362	262	141	-1,161	-1,416
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	48.82%	48.82%	49.3%	65.17%	54%	30.04%
Operating Margin	28.88%	28.88%	16.42%	30.07%	-2.22%	-16.44%
Profit Margin	22.02%	22.02%	17.26%	20.88%	-11.01%	-24.45%
Free Cash Flow Margin	21.81%	21.81%	4.58%	1.99%	-36.85%	-74.64%
EBITDA	2,541	1,854	1,017	2,200	-24	-273
EBITDA Margin	40.7%	29.69%	17.79%	31.15%	-0.76%	-14.39%
D&A For EBITDA	738	51	78	76	46	39
EBIT	1,803	1,803	939	2,124	-70	-312
EBIT Margin	28.88%	28.88%	16.42%	30.07%	-2.22%	-16.44%
Effective Tax Rate	23.61%	23.61%	-1.64%	0.47%	-4.53%	-2.2%

Follow-Up Questions

What are Bavarian Nordic A/S's key financial statements?



According to the latest financial statement (Form-10K), Bavarian Nordic A/S has a total asset of $14,954, Net profit of $1,375

What are the key financial ratios for BVNRY?



Bavarian Nordic A/S's Current ratio is 7.17, has a Net margin is 22.02, sales per share of $80.

How is Bavarian Nordic A/S's revenue broken down by segment or geography?



Bavarian Nordic A/S largest revenue segment is Life-Saving Vaccines, at a revenue of 5,716,206,000 in the most earnings release.For geography, United States is the primary market for Bavarian Nordic A/S, at a revenue of 2,702,900,000.

Is Bavarian Nordic A/S profitable?



yes, according to the latest financial statements, Bavarian Nordic A/S has a net profit of $1,375

Does Bavarian Nordic A/S have any liabilities?



yes, Bavarian Nordic A/S has liability of 2,084

How many outstanding shares for Bavarian Nordic A/S?



Bavarian Nordic A/S has a total outstanding shares of 78.47

Key Stats

Prev.Close

$9.65

Open

$9.67

Day's Range

$9.64 - $9.67

52 week range

$6.59 - $13

Volume

100

Avg.Volume

1.7K

Dividend yield

EPS (TTM)

1.62

Market Cap

$2.2B

What is Bavarian Nordic A/S?

Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in research and development innovations, production and commercialization of life-saving vaccines based on viral vectors for the delivery of antigens targeting infectious diseases. Bavarian Nordic A/S offers travel health products including cholera, rabies, tick-borne encephalitis and typhoid vaccines, as well as vaccines sold and distributed in selected markets on behalf of third parties. The firm deals with vaccines aimed at improving public health and preparedness. Bavarian Nordic A/S focuses on vaccine solutions that help address the threat of infectious diseases. The firm operates worldwide.



Features

AI Copilot for Stock & Crypto

Resources